Cargando…
Kynurenine aminotransferase II inhibition promotes sleep and rescues impairments induced by neurodevelopmental insult
Dysregulated sleep is commonly reported in individuals with neuropsychiatric disorders, including schizophrenia (SCZ) and bipolar disorder (BPD). Physiology and pathogenesis of these disorders points to aberrant metabolism, during neurodevelopment and adulthood, of tryptophan via the kynurenine path...
Autores principales: | Milosavljevic, Snezana, Smith, Andrew K., Wright, Courtney J., Valafar, Homayoun, Pocivavsek, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066394/ https://www.ncbi.nlm.nih.gov/pubmed/37002202 http://dx.doi.org/10.1038/s41398-023-02399-1 |
Ejemplares similares
-
The stress of losing sleep: Sex-specific neurobiological outcomes
por: Wright, Courtney J., et al.
Publicado: (2023) -
Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters
por: Jayawickrama, Gayan S., et al.
Publicado: (2018) -
Heterocyclic Cathinones as Inhibitors of Kynurenine Aminotransferase II—Design, Synthesis, and Evaluation
por: Maryška, Michal, et al.
Publicado: (2021) -
Acute sleep deprivation during pregnancy in rats: Rapid elevation of placental and fetal inflammation and kynurenic acid
por: Baratta, Annalisa M., et al.
Publicado: (2019) -
Kynurenine Aminotransferase Isozyme Inhibitors: A Review
por: Nematollahi, Alireza, et al.
Publicado: (2016)